Serum levels of interleukin-6, tumor necrosis factor-alpha, and interleukin-2 in rejecting human small bowel allografts.
Noguchi
K
K
Department of Pathology, University of Pittsburgh School of Medicine, Pennsylvania.
Yoshida
Y
Y
Yagihashi
A
A
Kita
Y
Y
Takenaka
T
T
Terasawa
K
K
Hayashi
S
S
Konno
A
A
Kobayashi
M
M
Nakamura
K
K
D000328:Adult; D015415:Biomarkers / Q000097:blood; D002648:Child; D006084:Graft Rejection; D006801:Humans; D007376:Interleukin-2 / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood*; D007421:Intestine, Small / Q000637:transplantation*; D016031:Liver Transplantation / Q000276:immunology*; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D015166:Monitoring, Immunologic / Q000379:methods; D014184:Transplantation, Homologous / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis*
D015415:Biomarkers; D007376:Interleukin-2; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D008776:Methylprednisolone Hemisuccinate